ロード中...
Haploidentical hematopoietic cell and kidney transplantation for hematological malignancies and end-stage renal failure
At Massachusetts General Hospital, we pioneered simultaneous hematopoietic cell (HCT)/kidney transplantation from HLA-identical related donors for the treatment of hematological malignancies with end-stage renal failure. We have now extended this to HLA-haploidentical donors in a pilot trial. Six re...
保存先:
| 出版年: | Blood |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6624971/ https://ncbi.nlm.nih.gov/pubmed/31151984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019000775 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|